Bioquell (BQE)

Company name:Bioquell
EPIC:BQE (delisted)Trading Currency:GBX
Market Sector:SQQ3ISIN:GB0004992003
Market Segment:SSQ3Share Type:DE
WWW Address: 10P
 Price Price Change [%] Bid Offer Open High Low Volume
 597.00 0.0 [0.00] - - - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 133.45 22.35 0.07 11.60 - 51.47 - -

Bioquell Key Figures

(at previous day's close)
Market Cap.133.45m
Shares In Issue22.35m
Prev. Close597.00
PE Ratio51.47 
Dividend Yield-%
EPS - basic11.60p
Dividend PS-p
Dividend Cover- 
Cash Flow PS31.09p
Return On Equity (ROE)10.06%
Operating Margin11.25%
PEG Factor0.06 
EPS Growth Rate792.31%
Dividends PS Growth Rate-%
Net Debt-6.50m
Gross Gearing23.21%
Quick Assets20.83m
Net Working Capital17.13m
Intangibles / Fixed Assets63.03%
Turnover PS130.59p
Pre-Tax Profit PS14.69p
Retained Profit PS12.04p
Cash PS65.25p
Net Cash PS34.38p
Net Tangible Asset Value PS *89.22p
Net Asset Value PS119.72p
Spread- (-%) 

Bioquell Balance Sheet


Share Price Performance

Sorry No Data Available

Share Price Chart (5 years)

Bioquell Historic Returns

Sorry No Data Available

Bioquell Key Management Ratios

Bioquell Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio10.41 
PE Ratio51.47 
Tobin's Q Ratio 4.07 
Tobin's Q Ratio (excl. intangibles)5.22 
Dividend Yield-%
Market-to-Book Ratio4.99 
Price-to-Pre-Tax Profit PS40.65 
Price-to-Retained Profit PS49.57 
Price-to-Cash Flow PS19.20 
Price-to-Sales PS4.57 
Price-to-Net Tangible Asset Value PS6.69 
Price-to-Cash PS9.15 
Net Working Capital PS76.65 
Price Pct to Working Capital PS7.79%
Earnings Yield1.94%
Average PE37.78 
Years in average4 
PE to PE average136.22%

Bioquell Financial Ratios

(Leverage Ratios)
Debt Ratio4.25%
Debt-to-Equity Ratio0.04 
Debt-to-Equity Ratio (excl. Intgbl)0.06 
Debt-to-Equity Market Value0.01 
Net Gearing-18.64%
Net Gearing (excl. Intangibles)-23.18%
Gross Gearing23.21%
Gross Gearing (excl. Intangibles)28.86%
Gearing Under 1 Year19.80%
Gearing Under 1 Year (excl. Intgbl)24.61%
(Liquidity Ratios)
Net Working Capital to Total Assets49.17%
Current Ratio3.48 
Quick Ratio (Acid Test)3.02 
Liquidity Ratio2.11 
Cash & Equiv/Current Assets60.69%
(Solvency Ratios)
Enterprise Value120.05m
CFO/Attributable Profit2.58 
Total Debt/Equity Market Value0.06 
Total Debt/Sales0.28 
Total Debt/Pre-Tax Profit2.46 
Total Debt8.09m
Total Debt/Net Current Assets0.47%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth9.71%
10 yr Compound Earnings Growth2.57%
Earn drops > 5% in 10yrs7 
Beta (60-Mnth)Beta (36-Mnth)

Bioquell Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)11.75%
Return On Assets (ROA)8.22%
Net Profit Margin9.22%
Assets Turnover0.89 
Return On Equity (ROE)10.06%
Return On Investment (ROI)10.22%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio10.64%
Net Income Of Revenues9.22%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.15 
Fixed Assets Turnover2.54 
Current Assets Turnover1.37 
Net Working Capital Turnover 
Inventory Turnover9.77 
(Other Operating Ratios)
Total Assets-to-Sales1.12 
Debt Collection Period82.41Days

Bioquell Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
18 Mar 2015FinalGBX3.3031/12/201331/12/201404/06/201505/06/201502/07/20153.30
18 Mar 2014FinalGBX3.3031/12/201231/12/201304/06/201406/06/201402/07/20143.30
19 Mar 2013FinalGBX3.0631/12/201131/12/201205/06/201307/06/201301/07/20133.06
20 Mar 2012FinalGBX2.8331/12/201031/12/201106/06/201208/06/201202/07/20122.83
15 Mar 2011FinalGBX2.6231/12/200931/12/201001/06/201103/06/201101/07/20112.62
16 Mar 2010FinalGBX2.4231/12/200831/12/200902/06/201004/06/201001/07/20102.42
24 Mar 2009FinalGBX2.2031/12/200731/12/200810/06/200912/06/200903/07/20092.20

Bioquell Fundamentals

 31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)
pre tax profit-1.36-3.00%0.632.35%0.080.28%3.2811.25%m
attributable profit-1.02-2.25%35.14130.74%0.401.48%2.699.22%m
retained profit-2.42-5.35%33.73125.51%0.401.48%2.699.22%m
eps - basic (p)-2.40 82.50 1.30 11.60 
eps - diluted (p)-2.40 81.80 1.20 11.60 
dividends per share3.30 - - - 

Bioquell Balance Sheet

 31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)
 31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)
fixed assets fixed assets14.2633.84%5.357.55%4.5714.92%3.9111.22%m
intangibles intangibles9.7123.06%8.7912.40%7.5724.69%6.8219.56%m
fixed investments fixed investments--%--%0.040.14%0.090.25%m
current assets - other current assets - other--%--%--%--%m
stocks stocks3.367.97%3.555.01%2.779.05%3.209.19%m
debtors debtors11.9728.40%5.607.91%6.9422.63%6.2417.92%m
cash & securities cash & securities2.846.74%47.5767.14%8.7628.57%14.5941.85%m
creditors - short creditors - short7.6518.15%4.596.47%5.9319.33%6.9019.80%m
creditors - long creditors - long3.438.14%1.351.91%0.892.90%1.193.41%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves31.0673.71%64.9291.62%23.8377.76%26.7676.79%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Bioquell Cash Flow Statement

31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)
Operating CF3.755.334.136.95m
Pre-Financing CF0.3746.862.946.01m
Retained CF-0.7144.72-39.085.97m

Bioquell Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Investec Bank PlcMarket Maker(MMF)Broker/DealerINV.IHCSGB21002
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200921 04:15:35